RPM Drosta has anti-estrogenic characteristics with little hepatotoxicity and practically zero fluid retention. These anti-estrogenic characteristics make it a safe drug with almost no side effects such as gynecomastia and high blood pressure.
MECHANISM OF ACTION
The mechanism of action of DROSTANOLONE is based on the following principles:
It works by promoting the increase in strength and muscle mass through various physiological mechanisms by increasing nitrogen retention.
It is myotropic as it acts in the cytoplasm of the muscle cell, it promotes the release of the alpha reductase enzyme in the nucleus, allowing RNA to take advantage of amino acids and proteins (nitrogen) from the diet to transform them into muscle tissue.
Likewise, it has the action of retaining calcium, phosphorus, potassium and chlorides. This action contributes to a greater development of the bones, also constituting a growth factor, as long as the recommended dosages are maintained. These contractive processes of mineralization and consolidation also allow bone regeneration in cases of rickets and osteomalacia.
Appetite stimulation through metabolic regulation.
It favors the absorption of the nutrients acquired by the diet or supplied as a supplement. Plantium power
Intramuscular route
FORMULA
Each 1 ml contains:
Drostanolone Propionate ……………………………. 100mg.
Excipients ……………………………………………. C.S.
Short-acting anabolic in injectable oily solution. DROSTANOLONE PROPIONATE offers the possibility of achieving an increase in strength and improvement of body mass, without achieving much increase in body weight.
THERAPEUTIC INDICATIONS
DROSTANOLONE PROPIONATE landerlan has its use in most cases it is done by athletes in phases of previous competition, cutting or simply to avoid water retention and estrogen peaks. For mass and volume drostanolone propionate is most effective in cycles with other drugs such as anabolic stanozolol, testosterone propionate and others.
Specific indications include:
Greater development of bone structure and increase in muscle mass.
Better and higher protein synthesis, mineral retention, improved appetite and feed conversion.
As an adjunct in wasting or debilitating diseases that cause weight loss, convalescent states, senile weakness, rickets, fractures (to promote the formation of bone callus) and stress situations (post-surgical, weaning, descres, castrations, changes of environment and prolonged summers or winters among others).
Any other situation in which it is required to promote protein synthesis.
ROUTES OF ADMINISTRATION AND DOSAGE
The recommended RPM Drosta 10ml Injection route is deep intramuscular, according to the following doses:
1 ml for every 90 kg of weight. Although the duration of treatment depends on the discretion of the doctor, the following dosage models are recommended:
OBSERVATIONS
Do not administer RPM Drosta 10ml Injection intravenously.
Do not mix in the same syringe or container with any other substance foreign to the product.
Keep the asepsis and antisepsis indications before and during the application of the product.
To obtain an adequate effect, it is important to maintain an adequate intake of proteins, calories, vitamins, iron and copper.
A slight swelling may appear at the site of inoculation, which disappears after a few days without the need for treatment.
Keep out of the reach of children and pets.
Do not smoke or eat while handling the product.
LIMITATIONS OF USE
If the masculinizing effects are very severe, the dose should be lowered or the treatment discontinued.
Other Veterinary Solution Includes:
Equizone 50/100 (Phenylbutazone) Powder
